Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways

Autophagy

Volumn 5, Issue 4, 2009, Pages 472-483

  Chiu, Hui Wen ^a   Ho, Sheng Yow ^b   Guo, How Ran ^a,c   Wang, Ying Jan ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAINAN SIN LAU HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Arsenic trioxide; Autophagy; Malignant gliomas; Mitotic arrest; Radiation

Indexed keywords

ARSENIC TRIOXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER CELL; CELL ORGANELLE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IRRADIATION; MITOSIS INHIBITION;

EID: 66349090851     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.5.4.7759     Document Type: Article

References (80)

1. Ning S, Knox SJ. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Int J Radiat Oncol Biol Phys 2004; 60:197-203. (Pubitemid 39165485)
2. Mamelak AN, Jacoby DB. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 2007; 4:175-186 (Pubitemid 46389915)
3. Ning S, Knox SJ. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma. Int J Radiat Oncol Biol Phys 2006; 65:493-498
4. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 2003; 63:2103-2108 (Pubitemid 36538613)
5. Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 1997; 89:3345-3353
6. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89:3354-3360
7. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001; 19:3852-3860 (Pubitemid 32880064)
8. Griffin R, Lee S, Rood K, Gales J, Sausville EA, O'Connor PM, et al. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia (New York) 2000; 2:555-560 (Pubitemid 32098690)
9. Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, et al. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgenindependent prostate cancer. Cancer Res 2001; 61:5432-5440 (Pubitemid 32694923)
10. Chun YJ, Park IC, Park MJ, Woo SH, Hong SI, Chung HY, et al. Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3). FEBS Lett 2002; 519:195-200. (Pubitemid 34522018)
11. Lew YS, Kolozsvary A, Brown SL, Kim JH. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor. Cancer Res 2002; 62:4202-4205 (Pubitemid 34827272)
12. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 2005; 24:980-991 (Pubitemid 40313875)
13. Cheng TJ, Wang YJ, Kao WW, Chen RJ, Ho YS. Protection against arsenic trioxide-induced autophagic cell death in U118 human glioma cells by use of lipoic acid. Food Chem Toxicol 2007; 45:1027-1038 (Pubitemid 46507693)
14. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa J. bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol (Berl) 1994; 88:520-526 (Pubitemid 24364699)
15. Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R. BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci 1998; 155:68-75. (Pubitemid 28141061)
16. Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S, Germano IM. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg 2003; 98:378-384 (Pubitemid 36151035)
17. Ito H, Daido S, Kanzawa T, Kondo S, Kondo Y. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol 2005; 26:1401-1410
18. Aldridge DR, Radford IR. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res 1998; 58:2817-2824 (Pubitemid 28311913)
19. Su LN, Little JB. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat Res 1993; 133:73-79 (Pubitemid 23070028)
20. Ling YH, Jiang JD, Holland JF, Perez-Soler R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol 2002; 62:529-538 (Pubitemid 36329371)
21. Li YM, Broome JD. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res 1999; 59:776-780 (Pubitemid 29086725)
22. Cai X, Yu Y, Huang Y, Zhang L, Jia PM, Zhao Q, et al. Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells. Leukemia 2003; 17:1333-1337 (Pubitemid 36857340)
23. 2 checkpoint activation in CGL-2 cells. Carcinogenesis 2005; 26:53-63.
24. Ho SY, Huang PC, Guo HR, Chang WH, Chen RJ, Wei BL, et al. Mechanisms of apoptosis induction and cell cycle regulation in irradiated leukemia U937 cells and enhancement by arsenic trioxide. Radiat Res 2006; 165:390-399
25. Bursch W, Ellinger A, Gerner C, Frohwein U, Schulte-Hermann R. Programmed cell death (PCD). Apoptosis, autophagic PCD or others? Annals of the New York Academy of Sciences 2000; 926:1-12.
26. Ogier-Denis E, Codogno P. Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 2003; 1603:113-128 (Pubitemid 36266686)
27. Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2004; 2:301-314 (Pubitemid 39490100)
28. Klionsky DJ, Cregg JM, Dunn WA Jr, Emr SD, Sakai Y, Sandoval IV, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003; 5:539-545 (Pubitemid 37243044)
29. Reggiori F, Klionsky DJ. Autophagy in the eukaryotic cell. Eukaryot Cell 2002; 1:11-21. (Pubitemid 36562345)
30. Blommaart EF, Luiken JJ, Meijer AJ. Autophagic proteolysis: control and specificity. Histochem J 1997; 29:365-385 (Pubitemid 27245088)
31. Klionsky D, Emr S. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-1721 (Pubitemid 32004796)
32. Meijer AJ, Codogno P. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 2004; 36:2445-2462 (Pubitemid 39119758)
33. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, et al. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 2001; 276:35243-35246 (Pubitemid 37384313)
34. Ogier-Denis E, Couvineau A, Maoret JJ, Houri JJ, Bauvy C, De Stefanis D, et al. A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29. J Biol Chem 1995; 270:13-16
35. 2/M arrest in U937 myeloid leukemia cells. J Pharmacol Exp Ther 2005; 313:877-887
36. 2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1. Exp Cell Res 1995; 220:226-231
37. Antonsson B, Montessuit S, Sanchez B, Martinou JC. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 2001; 276:11615-11623 (Pubitemid 37385313)
38. Narvaez CJ, Welsh J. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 2001; 276:9101-9107 (Pubitemid 37385490)
39. Lee DH, Park T, Kim HW. Induction of apoptosis by disturbing mitochondrial-membrane potential and cleaving PARP in Jurkat T cells through treatment with acetoxyscirpenol mycotoxins. Biol Pharm Bull 2006; 29:648-654
40. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001; 61:439-444 (Pubitemid 32128593)
41. Dagda RK, Zhu J, Kulich SM, Chu CT. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy 2008; 4:770-782
42. Corcelle E, Nebout M, Bekri S, Gauthier N, Hofman P, Poujeol P, et al. Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Res 2006; 66:6861-6870 (Pubitemid 44085647)
43. Kim KW, Hwang M, Moretti L, Jaboin JJ, Cha YI, Lu B. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 2008; 4:659-668
44. Ellington AA, Berhow MA, Singletary KW. Inhibition of Akt signaling and enhanced ERK1/2 activity are involved in induction of macroautophagy by triterpenoid B-group soyasaponins in colon cancer cells. Carcinogenesis 2006; 27:298-306. (Pubitemid 43159883)
45. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 2007; 72:29-39. (Pubitemid 46998522)
46. Vuky J, Yu R, Schwartz L, Motzer RJ. Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma. Invest New Drugs 2002; 20:327-330 (Pubitemid 34823761)
47. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304:1500-1502 (Pubitemid 38720930)
48. Xu Y, Kim SO, Li Y, Han J. Autophagy contributes to caspase-independent macrophage cell death. J Biol Chem 2006; 281:19179-19187 (Pubitemid 44035422)
49. Yu L, Wan F, Dutta S, Welsh S, Liu Z, Freundt E, et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA 2006; 103:4952-4957
50. Hoyer-Hansen M, Jaattela M. Autophagy: an emerging target for cancer therapy. Autophagy 2008; 4:574-580
51. Ng G, Huang J. The significance of autophagy in cancer. Mol Carcinog 2005; 43:183-187 (Pubitemid 41134425)
52. Liang XQ, Cao EH, Zhang Y, Qin JF. p53-induced gene 11 (PIG11) involved in arsenic trioxide-induced apoptosis in human gastric cancer MGC-803 cells. Oncol Rep 2003; 10:1265-1269
53. Zhao S, Tsuchida T, Kawakami K, Shi C, Kawamoto K. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status. Int J Oncol 2002; 21:49-55.
54. Ohneseit PA, Prager D, Kehlbach R, Rodemann HP. Cell cycle effects of topotecan alone and in combination with irradiation. Radiother Oncol 2005; 75:237-245 (Pubitemid 40805256)
55. Smits VA, Medema RH. Checking out the G(2)/M transition. Biochim Biophys Acta 2001; 1519:1-12.
56. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003; 22:5834-5847 (Pubitemid 37176704)
57. Wahl GM, Carr AM. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol 2001; 3:277-286 (Pubitemid 33130452)
58. Higginbottom K, Jahnke U, Newland AC, Cotter FE, Allen PD. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis. Apoptosis 2007; 12:1847-1855 (Pubitemid 47498240)
59. Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003; 22:9075-9086 (Pubitemid 38121708)
60. Ricci MS, Zong WX. Chemotherapeutic approaches for targeting cell death pathways. Oncologist 2006; 11:342-357
61. Gunn JM, Clark MG, Knowles SE, Hopgood MF, Ballard FJ. Reduced rates of proteolysis in transformed cells. Nature 1977; 266:58-60. (Pubitemid 8050013)
62. Kisen GO, Tessitore L, Costelli P, Gordon PB, Schwarze PE, Baccino FM, et al. Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis 1993; 14:2501-2505 (Pubitemid 24016585)
63. Sampath D, Plunkett W. Design of new anticancer therapies targeting cell cycle checkpoint pathways. Curr Opin Oncol 2001; 13:484-490 (Pubitemid 33027901)
64. Bursch W, Hochegger K, Torok L, Marian B, Ellinger A, Hermann RS. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci 2000; 113:1189-1198 (Pubitemid 30229536)
65. Alemany M, Levin J. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages. Leuk Lymphoma 2000; 38:153-163
66. Cohen I, Castedo M, Kroemer G. Tantalizing Thanatos: unexpected links in death pathways. Trends Cell Biol 2002; 12:293-295
67. Rodriguez-Enriquez S, He L, Lemasters JJ. Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int J Biochem Cell Biol 2004; 36:2463-2472 (Pubitemid 39119759)
68. Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, Lee SJ, et al. Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res 2007; 67:6314-6324 (Pubitemid 47037514)
69. Pattingre S, Bauvy C, Codogno P. Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 2003; 278:16667-16674 (Pubitemid 36799530)
70. Ogier-Denis E, Pattingre S, El Benna J, Codogno P. Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J Biol Chem 2000; 275:39090-39095 (Pubitemid 32058923)
71. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004; 23:2891-2906 (Pubitemid 38638851)
72. McCabe MJ Jr, Singh KP, Reddy SA, Chelladurai B, Pounds JG, Reiners JJ Jr, et al. Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment and cell cycle phase. J Pharmacol Exp Ther 2000; 295:724-733
73. 2 + M phase by sodium arsenite at lower doses. Eur J Haematol 1998; 61:27-35.
74. Doherty SC, McKeown SR, McKelvey-Martin V, Downes CS, Atala A, Yoo JJ, et al. Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst 2003; 95:1859-1868 (Pubitemid 38054686)
75. 1 cell cycle arrest and apoptosis induced by terfenadine in human cancer cells. Mol Carcinog 2003; 37:39-50.
76. Ho YS, Wang YJ, Lin JK. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog 1996; 16:20-31. (Pubitemid 26191258)
77. Traganos F, Darzynkiewicz Z. Lysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulations. Methods Cell Biol 1994; 41:185-194
78. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007; 3:542-545 (Pubitemid 350060049)
79. Yokoyama T, Miyazawa K, Naito M, Toyotake J, Tauchi T, Itoh M, et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy 2008; 4:629-640
80. Peng PL, Kuo WH, Tseng HC, Chou FP. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 2008; 70:529-542